VACCINE ADJUVANT DISCOVERY PROGRAM
$1,637,656
| Recipient | UNIVERSITY OF MONTANA UEI DAY7Z8ZD48Q3 |
|---|---|
| Award ID | 75N93024C00024 |
| Award amount | $1,637,656 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — National Institutes of Health |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | AN12 |
| Start date | Sep 30, 2024 |
| End date | Sep 29, 2029 |
| Place of performance | MISSOULA, MT |
| Record updated | Sep 22, 2024 |
View the official award record
More awards won by UNIVERSITY OF MONTANA
NON-SEVERABLE BASE PERIOD 09/30/2018-09/29/2021
Department of Health and Human Services · $18,280,027 · Sep 30, 2018
TO DEVELOP INNOVATIVE AND SAFE MULTIVALENT ANTI-OPIOID VACCINES THAT PROTECT AGAINST HEROIN AND FENTANYL.
Department of Health and Human Services · $17,760,139 · Sep 30, 2020
TO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES.
Department of Health and Human Services · $15,637,406 · Sep 6, 2019
IGF::OT::IGF ADJUVANT DISCOVERY PROGRAM
Department of Health and Human Services · $13,735,694 · Sep 23, 2014
DEVELOPMENT OF UM-1098: A NOVEL SYNTHETIC TH17 INDUCING ADJUVANT AND DELIVERY SYSTEM
Department of Health and Human Services · $9,566,206 · Sep 30, 2023
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids